Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Million
Read Article
News
2024
2023
Archive
Search news articles
August 8, 2017
APREA THERAPEUTICS ANNOUNCES FIRST PATIENT ENROLLED IN PHASE IB/II CLINICAL STUDY OF APR-246 FOR THE TREATMENT OF PLATINUM-RESISTANT HIGH-GRADE SEROUS OVARIAN CANCER
August 4, 2017
KINESTRAL TECHNOLOGIES RECEIVES THE 2017 NORTH AMERICAN SMART GLASS NEW PRODUCT INNOVATION AWARD
August 1, 2017
HOMOLOGY MEDICINES ANNOUNCES $83.5 MILLION SERIES B FINANCING TO ADVANCE LEAD DEVELOPMENT CANDIDATE AND AMENDR™ IN VIVO GENE EDITING TECHNOLOGY
July 13, 2017
CRINETICS PHARMACEUTICALS AWARDED $2.8 MILLION SBIR GRANT TO SUPPORT DEVELOPMENT OF ACROMEGALY DRUG CANDIDATE CRN00808
July 12, 2017
PORTAL INSTRUMENTS APPOINTS WENDY DWYER AS CHIEF BUSINESS OFFICER
June 27, 2017
VIVEVE SELECTED FOR INCLUSION IN RUSSELL 2000(R) INDEX
June 20, 2017
SPYRYX BIOSCIENCES EXPANDS DEVELOPMENT AWARD WITH CYSTIC FIBROSIS FOUNDATION; PRESENTS PHASE 1 DATA FOR SPX-101 AT THE EUROPEAN CYSTIC FIBROSIS CONFERENCE
June 12, 2017
NEEDLE-FREE INJECTION – PORTAL PRIME: A DIGITALLY CONTROLLED, CLOUD-INTEGRATED JET INJECTION SYSTEM
June 7, 2017
BIRD ROCK BIO COMPLETES SINGLE ASCENDING DOSE HUMAN CLINICAL TRIAL FOR NAMACIZUMAB; GENERATES SAFETY, TOLERABILITY, AND PHARMACOKINETICS DATA; PREPARES TO INITIATE STUDY IN NON-ALCOHOLIC FATTY LIVER DISEASE PATIENTS
May 24, 2017
PIERRE FABRE BUYS UP IGENICA PRECLINICAL I-O MEDS
« Previous Page
1
…
69
70
71
72
73
…
103